Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Preskorn

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Psychopharmacology Series|January 1, 1989
Therapeutic drug monitoring of tricyclic antidepressants: a means of avoiding toxicityS H Preskorn
Clinical Cornerstone|February 22, 2000
Antidepressant options in primary careS H Preskorn
Psychopharmacology Bulletin|January 1, 1991
Should bupropion dosage be adjusted based upon therapeutic drug monitoring?S H Preskorn
Journal of Clinical Psychopharmacology|August 1, 1994
Therapeutic drug monitoring with tricyclic antidepressants: a responseS H Preskorn
The Journal of Clinical Psychiatry|January 1, 1997
Selection of an antidepressant: mirtazapineS H Preskorn
The Journal of Clinical Psychiatry|July 1, 1989
Tricyclic antidepressants: the whys and hows of therapeutic drug monitoringS H Preskorn
Journal of Psychiatric Practice|July 2, 2005
The human genome project and drug discovery in psychiatry: identifying novel targetsS H Preskorn
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Debate resolved: there are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymesS H Preskorn
Psychopharmacology Series|January 1, 1993
Dose-effect and concentration-effect relationships with new antidepressantsS H Preskorn
The American Journal of Psychiatry|December 1, 1996
Effects of antidepressants on the cytochrome P450 systemS H Preskorn
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Psychopharmacology Series|January 1, 1989
Therapeutic drug monitoring of tricyclic antidepressants: a means of avoiding toxicityS H Preskorn
Clinical Cornerstone|February 22, 2000
Antidepressant options in primary careS H Preskorn
Psychopharmacology Bulletin|January 1, 1991
Should bupropion dosage be adjusted based upon therapeutic drug monitoring?S H Preskorn
Journal of Clinical Psychopharmacology|August 1, 1994
Therapeutic drug monitoring with tricyclic antidepressants: a responseS H Preskorn
The Journal of Clinical Psychiatry|January 1, 1997
Selection of an antidepressant: mirtazapineS H Preskorn
The Journal of Clinical Psychiatry|July 1, 1989
Tricyclic antidepressants: the whys and hows of therapeutic drug monitoringS H Preskorn
Journal of Psychiatric Practice|July 2, 2005
The human genome project and drug discovery in psychiatry: identifying novel targetsS H Preskorn
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Debate resolved: there are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymesS H Preskorn
Psychopharmacology Series|January 1, 1993
Dose-effect and concentration-effect relationships with new antidepressantsS H Preskorn
The American Journal of Psychiatry|December 1, 1996
Effects of antidepressants on the cytochrome P450 systemS H Preskorn
Pageof 15